Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Retina (Philadelphia, Pa.)|January 3, 2018
CLINICAL FINDINGS IN TRIAMCINOLONE-ASSOCIATED MACULOPATHYHoward F Fine, Edith R Reshef, Jonathan L Prenner, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|May 26, 2021
Scleral Buckle Removal: Indications, Timing, Complications, and Long-Term OutcomesHamoon Eshraghi, Jonathan L Prenner, Rui Zhang, et al.
The British Journal of Ophthalmology|May 29, 2020
Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN studySam E Mansour, Daniel F Kiernan, Daniel B Roth, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|February 16, 2016
Post-Marketing Survey of Adverse Events Following OcriplasminSumit P Shah, Karen W Jeng-Miller, Howard F Fine, et al.
Retina (Philadelphia, Pa.)|February 28, 2020
THE EFFECT OF ELECTIVE CATARACT EXTRACTION BY PHACOEMULSIFICATION IN EYES WITH VITREOMACULAR TRACTION SYNDROMEDimosthenis Mantopoulos, Jonathan L Prenner, Vishal K Patel, et al.
Ophthalmology. Retina|May 4, 2019
Macula Society Collaborative Retrospective Study of Ocriplasmin for Symptomatic Vitreomacular AdhesionJennifer I Lim, Adam R Glassman, Lloyd Paul Aiello, et al.
Retina (Philadelphia, Pa.)|July 13, 2013
Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study)Antonio Capone, Michael A Singer, David G Dodwell, et al.
BMC Ophthalmology|September 5, 2015
Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review studyPravin U Dugel, Antonio Capone, Michael A Singer, et al.
BMC Ophthalmology|April 18, 2015
Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review studyMichael A Singer, Antonio Capone, Pravin U Dugel, et al.
Ophthalmology|June 7, 2011
The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosingJeffrey S Heier, David Boyer, Quan Dong Nguyen, et al.
Pageof 5